Skip to main content
FinSpry Logo
FinSpry
CSTL logo
CSTL
(NASDAQ)
Castle Biosciences, Inc.
$33.47-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Castle Biosciences (CSTL) Stock Price & Financial Analysis

Castle Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$31.70 - $34.54
52-Week High$44.28
52-Week Low$17.72
Open$33.65
Volume356.86K
Average Volume (3M)459.53K
Market Cap1.02B
Shares Outstanding30.40M
Price to Sales (P/S)2.55
Price to Book (P/B)1.94
EV/EBITDA-177.89
Revenue (TTM)357.28M
Net Income (TTM)-19.41M
Free Cash Flow (TTM)-489.00K
EPS (TTM)$-0.65
Profit Margin-5.43%
Operating Margin-8.99%
Return on Equity (ROE)-4.13%
Debt to Equity0.02
50-Day MA$24.93
200-Day MA$29.29
52-Week Change49.08%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Castle Biosciences

What is the current stock price for CSTL?

As of the latest trading session, CSTL stock trades at $33.47. The 52-week range is $17.72–$44.28, with a day range of $31.70–$34.54.

What is the P/E ratio for CSTL?

The P/E ratio (Price-to-Earnings) for CSTL is shown in the Key Statistics section. This valuation metric helps compare Castle Biosciences, Inc. to industry peers.

Does CSTL pay dividends?

Castle Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CSTL?

Based on 2 analysts, the consensus for CSTL is Buy.

What is the market cap of CSTL?

Castle Biosciences's market capitalization is $1.02B, classifying it as a small-cap company. Castle Biosciences operates in the Healthcare sector within the Diagnostics & Research industry.